Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0001235802-23-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-17 | 2023-08-15 | XTNT | MITCHELL-KELLER LORI D | Dir | A - Grant | $0.00 | +145.2K | 191.0K | +317% | $0 |
| D | 2023-08-17 | 2023-08-15 | XTNT | MITCHELL-KELLER LORI D | Dir | A - Grant | $0.00 | +28.2K | 28.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | A | A | 145,180 | $0.00 | 190,962 | D | — | — | (F1) These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest and become issuable on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. (F2) Includes 145,180 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 45,782 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, all conditioned upon the Reporting Person remaining a director of Xtant through the vesting dates. |
| 2 | Derivative | Stock Option (right to buy) | 2023-08-15 | A | A | 28,230 | $0.00 | 28,230 | D | $1.20 · — to 2033-08-15 | 28,230 Common Stock | (F3) This option vests on August 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. |